Presentation Information
[P080(ST1)]Preclinical study of PfRipr5 formulated with human-compatible adjuvants for blood-stage malaria vaccine development
○Eizo Takashima1, Hikaru Nagaoka1, Hidenori Kimura2, Akihisa Fukushima2, Takafumi Tsuboi3 (1. Division of Malaria Research, Proteo-Science Center, Ehime University (Japan), 2. Vaccines, Sumitomo Pharma (Japan), 3. Division of Cell-free Science, Proteo-Science Center, Ehime University (Japan))
Password required to view
Comment
To browse or post comments, you must log in.Log in